key: cord-0320215-fvvotkjc
authors: Kamel, Wael; Ruscica, Vincenzo; Garcia-Moreno, Manuel; Palmalux, Natasha; Iselin, Louisa; Hannan, Maximilian; Järvelin, Aino; Noerenberg, Marko; Moore, Samantha; Merits, Andres; Davis, Ilan; Martinez, Javier; Mohammed, Shabaz; Castello, Alfredo
title: Compositional analysis of Sindbis virus ribonucleoproteins reveals an extensive co-opting of key nuclear RNA-binding proteins
date: 2021-10-08
journal: bioRxiv
DOI: 10.1101/2021.10.06.463336
sha: 060a3f7afcb95ba4762a42205515238fe70d4979
doc_id: 320215
cord_uid: fvvotkjc

The expansion of tropical mosquito habitats and associated arboviruses is a risk for human health, and it thus becomes fundamental to identify new antiviral strategies. In this study we employ a new approach to elucidate the composition of the ribonucleoproteins (RNPs) of a prototypical arbovirus called Sindbis (SINV). SINV RNPs contain 453 cellular and 6 viral proteins, many of these proteins are nuclear in uninfected cells and redistribute to the cytoplasm upon infection. These findings suggest that SINV RNAs act as ’spiderwebs’, capturing host factors required for viral replication and gene expression in the cytoplasm. Functional perturbation of several of these host proteins causes profound effects in virus infection, as illustrated here with the tRNA ligase complex. Moreover, inhibition of viral RNP components with available drugs hampers the infection of a wide range of viruses, opening new avenues for the development of broad-spectrum therapies. Research highlights SINV RNA interactome includes 453 cellular and 6 viral proteins. Nuclear RBPs that interact with SINV RNA are selectively redistributed to the cytoplasm upon infection The tRNA ligase complex plays major regulatory roles in SINV and SARS-CoV- 2 replication The SINV RNA interactome is enriched in pan-viral regulators with therapeutic potential.

The alphavirus genus contains several arthropod-borne viruses (arboviruses) that can 15 complete the viral life cycle (Strauss and Strauss, 1994) . The genomic (g)RNA of 30 alphavirus plays a dual role in infection, acting as genome but also as messenger 31 Over the last few years, several approaches have been developed to elucidate the 7 composition of viral ribonucleoproteins (vRNPs) within cells, and two of these have 8 been applied to alphaviruses (Iselin et al., 2021) . Viral cross-linking and solid-phase 9 purification (VIR-CLASP) was recently used to study the scope of protein-RNA 10 interactions mediated by alphavirus RNA after entry into the cell (Kim et al., 2020) . It 11 employs viral particles containing vRNA labelled with the photo-activatable nucleotide To fill this gap in our understanding of post-replicative alphavirus RNPs, we have 25 developed a novel proteome-wide approach called viral RNA interactome capture 26 (vRIC) (Kamel et al., 2021) . Here we show that the RNAs of the prototypical alphavirus 27

Sindbis virus (SINV) interact with 453 cellular and 6 viral proteins. SINV RNPs contain 28 host proteins involved in a broad range of processes, including translation, RNA 29 decay, splicing, formation of RNA granules and immunity. Amongst these, we noticed promoter controlled by deoxycycline (Dox). ActD and, particularly, Fvo strongly 31 suppressed eGFP expression, whereas DRB had only a mild effect ( Figure S1B ). 1 Therefore, we selected Fvo for further experiments since it strongly inhibits RNAPII 2 transcription while causing negligible effects on SINV gene expression. 3

Next, we optimised the 4SU pulse, aiming for efficient incorporation into vRNA without 4 affecting viral replication. When SINV-mCherry and 4SU were added simultaneously 5 to cells, viral gene expression was inhibited in a dose-dependent manner ( Figure S1C  6 and D). The inhibitory effect of 4SU was prevented when its addition was delayed for 7 2h ( Figure S1E ). 4SU and Fvo were also non-toxic for SFV ( Figure S1F ) and SARS-8

CoV-2 (Kamel et al., 2021) when added after 2 hours post infection (hpi), which 9

indicates that vRIC can be adapted to a wide range of viruses. 10

To elucidate the composition of SINV RNPs, we implemented the optimised conditions 11 into the vRIC protocol and applied it to SINV-infected cells. We included in our 12 proteomic analyses ( Figure S2A -E) all the controls schematised in Figure 1B enriched in oligo(dT) eluates in a 4SU-dependent manner, 723 with 1% false discovery 29 rate (FDR) plus an additional 74 with 10% FDR ( Figure 1F , Table 1 ). As expected, 30 these proteins are heavily enriched in known RBPs, with 83% of the proteins 31 previously identified by RNA interactome capture (RIC) studies in human cells (Hentze 32 et al., 2018) . We noticed that a small set of 144 RBPs were enriched in Fvo-treated 1 mock samples (M/4SU/Fvo) over Fvo-untreated ones (M/4SU/-), with 'mitochondrial 2 mRNA processing' factors being dominant amongst them ( Figure 1G -I, Table 3 ). 3

These proteins likely derive from the isolation of mitochondrial RNAs as they have 4 poly(A) tail in mammalian cells (Temperley et al., 2010) , and RNAPII inhibitors do not 5 affect the mitochondrial RNAP (Barchiesi and Vascotto, 2019; Dhir et al., 2018) . We 6 refer to this group of Fvo-insensitive proteins as mitoRNP given the prevalence of 7 mitochondrial proteins. 8

In contrast to uninfected cells, a rich protein pattern was observed in SINV-infected 9 cells, even in presence of Fvo ( Figure 1C, lanes 4 and 5) . These results agree with 10 notion that viral RdRps are insensitive to Fvo enabling 4SU incorporation. SINV To further understand the differences between vRNP and cRNP components, we 25 analysed their binding profiles, when available, using the ENCODE-eCLIP database 26 and we grouped them based on their binding preferences within the RNA architecture 28 ( Figure 2H ). Interestingly, vRNP components are enriched in RBPs that typically bind 29 to 5' and 3' untranslated regions (UTRs), while cRNPs have a higher proportion of 30 intron binding RBPs. This compositional bias highlights the importance of the 5' and 31 3' UTRs of SINV RNAs for replication and translation and the lack of RNA splicing in 1 the alphavirus life cycle (Carrasco et al., 2018; Strauss and Strauss, 1994) . 2

Unveiling the subset of SINV proteins that interact with vRNA 3 vRIC identified six viral proteins within vRNPs, which includes the non-structural 4 proteins nsP1, nsP2, nsP3 and nsP4 and the structural proteins caspid and E2 ( Figure  5 2A, S2K and Table 4 ). To determine whether these viral proteins are captured due to 6 a bona fide interaction with RNA or because of their high abundance in infected cells, 7

we normalized their intensities in vRIC eluates to those in the whole cell proteome 8 ( Figure 2H ). Capsid displayed the highest "crosslink-ability", as expected from its 9 involvement in the packing of viral genomes into virions (Sokoloski et al., 2017) . It was 10 followed by the non-structural proteins, which are essential for viral replication ( Figure  11 2I), including the capping enzyme nsP1, the helicase nsP2 and the RNA-dependent 12 RNA polymerase nsP4. Interestingly, we noticed that nsP3 also interacts with vRNA 13 in infected cells, but unlike the other non-structural proteins, nsP3 potential interaction 14 with vRNA remains poorly understood (Gotte et al., 2018 RNA-binding site placed at the AUD domain ( Figure 2I ). While the nsP3 peptide 20 coverage was high in vRIC eluates, supporting that it binds to vRNA ( Figure 2I ), its 21 crosslinking efficiency was substantially lower than that of the other nsPs ( Figure 2H) , 22

likely reflecting a more transitory or geometrically suboptimal interaction with vRNA. 23

Surprisingly, vRIC data showed that E2 also interacts with RNA ( Figure 2H transferred to endosome-derived membranous compartments in the cytoplasm (CPV-5 1) (Frolova et al., 2010) . Surprisingly, we noticed that a substantial proportion of the 6 proteins that interact with SINV RNA are nuclear ( Figure 3A ). As SINV infection causes 7 a profound shut off of the novo protein synthesis (Carrasco et al., 2018) , the most 8 likely scenario is that this cohort of nuclear RBPs is relocated to the cytoplasm where 9 they engage with vRNA. To test this globally, we performed nuclear/cytoplasmic 10 fractionation of mock-and SINV-infected cells followed by quantitative proteomics. 11

After fraction and quality control check with known nuclear and cytoplasmic proteins 12 Altogether, these data revealed that nuclear RBPs that interact with SINV RNA 23 partially relocate to the cytoplasm upon infection. 24

To assess in further detail the magnitude and directionality of these changes in 25 localisation, we generated a redistribution index for each protein (i.e. 26 cytoplasmic/nuclear protein intensity ratio in mock versus infected cells) ( Figure S3D ). 27

Cellular proteins can be classified depending on their localization as i) nuclear ii) 28 nuclear/cytoplasmic and ii) cytoplasmic, however for simplicity we grouped them into Figure 3D and S3E). Altogether, this data strongly indicates that SINV RNA 6 is the main driver for the cytoplasmic location of a defined subset of nuclear RBPs. 7

To validate these results, we next tested by western blotting the subcellular localisation 8

of RBPs significantly up-or downregulated in the cytoplasmic or the nuclear fractions 9

after SINV infection, particularly MATR3, AQR, GLTSCR2 and SFB1 ( Figure 3E -G, 10 Tables 5 and 6 ). Western blotting analysis revealed that all these proteins displayed 11

an increased presence in the cytoplasm of SINV infected cells when compared to the 12 mock control, while the location of the nuclear and cytoplasmic controls GAPDH and 13

LaminB remained unaltered, further corroborating our results ( Figure 3H ). GO analysis 14 revealed that most of the RBPs with high redistribution index are involved in splicing 15 or have nucleolar localisation ( Figure 3I ). Strikingly, many of these shuttling proteins Altogether, our results reveal that a defined set of cellular RBPs relocalise from the 31 nucleus to the cytoplasm upon SINV infection, and that these changes are most likely 1 driven by vRNA. in the cytoplasm of SINV-infected cells ( Figure S4A and Table 5 ), and RTCB, DDX1 11 and FAM98A accumulate in SINV ( Figure S4B ). Collectively, these multiple lines of 12 evidence ranked the tRNA-LC amongst the top five complexes with regulatory 13 potential ( Figure 4A ). minor or no effect on viral gene expression ( Figure 5A ). These contrasting results are 20 associated with a reduction in the abundance of all the other components of the tRNA-21 LC, including the ligase RTCB, upon DDX1 KD that is not observed with FAM98A KD 22 ( Figure S4C ). This loss of tRNA-LC components in absence of DDX1 is not due to a 23 decrease in the levels of their cognate mRNAs ( Figure S4D ). DDX1-dependent 24 disruption of the tRNA-LC was already observed in A549-ACE2 cells and suggests 25 that DDX1 is essential for the assembly and stability of the tRNA-LC complex, while 26 In a parallel work we showed that DDX1 KD also hampers SARS-CoV-2 infection 28 infection is similar to SINV, we analysed RNA-seq data from A549-ACE2 DDX1 KD 30 cells infected with SARS-CoV-2. In agreement to SINV, both positive and negative 31 sense RNAs of SARS-CoV-2 were severely reduced by DDX1 KD ( Figure S5A and 32 B). Collectively, these results show that the tRNA-LC has wide spread regulatory roles 1 in virus replication, although its exact mechanism of action awaits to be deciphered. 2

The tRNA-LC illustrates the power of vRIC at identifying key regulators of the viral life 4 cycle. However, this example is likely to be the tip of the iceberg. To assess the 5 incidence of regulators of the viral life cycle within SINV RNP components, we 6 performed a metanalysis of 73 genome-wide screenings focused on the discovery of We reasoned that if the vRNP composition is critical for virus infection, then cellular 23

proteins that interact with vRNA should be inherently enriched in potential targets for 24 antiviral therapies. To test this hypothesis, we identified the RBPs within SINV RNPs 25 with available inhibitors, and found 23 putative 'therapeutic targets' with 124 verified 26 inhibitors ( Figure S6D ). Out of these, we selected two classes of compounds: the first-27 class targets RBPs with domains involved in nucleic acid processing and modification, 28 such as 5-Azacytidine that inhibits 5-methylcytosine (m 5 C) methyltranferases (DNMT1 29 and NOP2/NSUN1) and Topotecan that do so with topoisomerase I (TOP1). The 30

second class targets kinases that can potentially modulate the vRNP 31 microenvironment, which included PF-480056 and PF-3758309 that inhibit CSNK1E 32 and PAK4, respectively. We tested the effects of these inhibitors in the viral fitness of 1 SINV-mCherry, SFV-mCherry and RRV-mCherry. 5-Azacytidine (cytosine 2 methyltransferases inhibitor) and Topotecan (TOP1 inhibitor) inhibited the infection of 3 these three alphaviruses in a dose-dependent manner, strongly reducing viral RNA 4 and proteins ( Figure 6C-E) . Moreover, we also noticed a dose-dependent decrease 5 of vRNA in the supernatant of infected cells, which implies reduction in viral particle 6 production ( Figure 6F ). These strong inhibitory effects were not associated with 7 viability defects due to toxicity ( Figure S6E Beads were resuspended in 300 μL of elution buffer and incubated for 3 min at 55°C 26 with agitation. After collecting the beads with a magnet, eluates (supernatants) were 27 collected and stored at −80°C. The lysates were subjected to a second round of 28 capture and the eluates from the first and second cycles were combined. Prior to mass 29 spectrometry sample processing, samples were RNase treated with ~0.02U RNase A 30

and RNase T1 at 37°C for 1h. The controls described in Figure 1B were generated as 31 above but virus, Fvo or/and UV irradiation were omitted. 150 mM NaCl, and 50mM HEPES, pH 7.9 and 0.1 mM AEBSF serine protease 10 inhibitor) supplemented with Benzonase (1 µL/mL) and incubated on ice for 1 hour. 11

Next, Nuclear lysate was boiled for 2 min and cleared by centrifugation at 15,000g for 12 5 min. For proteomic analysis four biological replicates were created. 13 replicates were used for the proteomic experiment. 28

To prepare whole cell lysate for western blotting, virus-and mock-infected cells were 1 harvested at the times indicated in the figures, washed once with 1X PBS and 2 resuspended in RIPA buffer 0.1% SDS, 0.5% sodium deoxycholate, 150 mM NaCl, 3 and 50mM HEPES, pH 7.9 and 0.1 mM AEBSF serine protease inhibitor) 4

supplemented with Benzonase (1 µl/ml) and incubated on ice for 1 hour. Next, total 5 lysate was boiled for 2 min and cleared by centrifugation at 15,000g for 5 min. Western 6 blotting was performed as previously described in (Garcia-Moreno et al., 2019) , 7

antibodies used are listed in Table 9 . Reverse transcription and qRT-PCR analysis was performed by Luna universal one-30 step qRT-PCR kit (NEB # E3005L) with primers list in Table 9 . 31

The plasmid expressing DDX1-K52A was generated by site-directed mutagenesis 2 using pcDNA5-FRT-TO-eGFP-DDX1 (Garcia-Moreno et al., 2019) as a template. 3

Primers are listed in Table 9 . The mutagenesis was confirmed by sequencing. signal measurement assay, HEK293 FlpIn TRex GFP cells were induced with 1ug/ml 12 doxycycline, prior to incubation in the microplate reader. 13

To test cell viability and proliferation at the concentrations used, we seeded 7. Table 9 . 23

Proteins samples (vRIC ,PPI eluates, cytoplasmic and nuclear fractions lysates) were 25 treated with benzonase (1 µL/mL) followed by clean-up via the bead-based single-pot, 26

solid-phase-enhanced sample-preparation (SP3) method, using Magnetic 27

Carboxylate Modified Particles beads (Sigma-Aldrich, cat.no.45152105050250). 28

Protein digestion was performed on beads using Trypsin Gold (MS grade; Promega, 29 cat. no. V5280), as previously described in (Hughes et al., 2019) . For processed 1 peptides, liquid chromatography (LC) was performed using an Ultimate 3000 ultra-2

PepMap100 pre-column (300 µm inner diameter x 5 mm, 100A, Thermo Fisher 4 applying the empirical Bayesian method moderated t-test with p-values adjusted for 2 multiple-testing using Benjamini-Hochberg method. For the vRIC samples, protein 3 intensities were processed as described above but omitting the normalization step. 

In order to identify potential inhibitor for vRNPs, we mined known chemical compound 24 interactions available through the Drug-Gene Interaction database (DGIdb, 25

downloaded Oct-2020) (Cotto et al., 2018) , and selected interactions with inhibitory 26 mode of action (reported as "inhibitor"). 27

Prediction of intrinsically disordered regions were obtained from MobiDB done by 1

MobiDB-lite method (Piovesan et al., 2021) . Assigning RNA binding proteins with 2 either classical or non-classical domains was performed as previously described in 3 (Kamel et al., 2021) . 4

To identify known RNP complex bound to viral RNA, list of curated human complexes 6 obtained from CORUM database (Giurgiu et al., 2019) . Complexes with less than 3 7 verified RBPs, based on RBPbase, were filtered out. The remaining complexes were 

Orally delivered siRNA targeting macrophage Map4k4 4 suppresses systemic inflammation

Cotranslational prolyl 6 hydroxylation is essential for flavivirus biogenesis

The host nonsense-mediated 9 mRNA decay pathway restricts Mammalian RNA virus replication

Transcription, Processing, and Decay of 12

Mitochondrial RNA in Health and Disease

The RNA-binding proteomes 15 from yeast to man harbour conserved enigmRBPs

The invasive mosquito 17 species Aedes albopictus: current knowledge and future perspectives

The Regulation of 20 Translation in Alphavirus-Infected Cells

Insights into 23 RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins

Comprehensive Identification of RNA-Binding 27 Domains in Human Cells

System-wide identification of RNA-binding 30 proteins by interactome capture

Translation of Sindbis 32 virus 26S mRNA does not require intact eukariotic initiation factor 4G

RNA-binding 36 activity of TRIM25 is mediated by its PRY/SPRY domain and is required for 37 ubiquitination

DGIdb 3.0: a redesign and 2 expansion of the drug-gene interaction database

Andromeda: a peptide search engine integrated into the MaxQuant 6 environment

Mitochondrial double-stranded RNA triggers 9 antiviral signalling in humans

The importance 11 of virion-incorporated cellular RNA-Binding Proteins in viral particle assembly and 12 infectivity

Discovery and functional interrogation 15 of SARS-CoV-2 RNA-host protein interactions

Functional Sindbis virus replicative complexes are formed at the plasma membrane

Binary 20 classification of protein molecules into intrinsically disordered and ordered segments

Utilization of 24 host SR protein kinases and RNA-splicing machinery during viral replication

Multiple roles 27 of the non-structural protein 3 (nsP3) alphavirus unique domain (AUD) during 28

Chikungunya virus genome replication and transcription

Unconventional RNA-30 binding proteins step into the virus-host battlefront

System-wide 34 Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection

Comparative analyses of 37 alphaviral RNA

CORUM: the comprehensive resource of 2 mammalian protein complexes-2019

The Enigmatic Alphavirus Non-4 Structural Protein 3 (nsP3) Revealing Its Secrets at Last

RNA binding regulates TRIM25-7 mediated RIG-I ubiquitylation

A brave new world of 9 RNA-binding proteins

RNA Helicase 11 DDX3: A Double-Edged Sword for Viral Replication and Immune Signaling

The Small Non-15 coding Vault RNA1-1 Acts as a Riboregulator of Autophagy

Single-pot, solid-phase-enhanced sample preparation for proteomics 19 experiments

Discriminating Self and Non-Self by RNA: 21 Roles for RNA Structure, Misfolding, and Modification in Regulating the Innate 22 Immune Sensor PKR

Uncovering viral RNA-host cell interactions on a proteome-wide scale

The new (dis)order 27 in RNA regulation

Capping pores of 29 alphavirus nsP1 gate membranous viral replication factories

The mammalian tRNA ligase 32 complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma 33 cells

Global analysis of 36 protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of 37 infection

Discovery of Widespread Host 2 Protein Interactions with the Pre-replicated Genome of CHIKV Using VIR-CLASP

Causative agent of 5

Pogosta disease isolated from blood and skin lesions

Sindbis viruses and other 7 alphaviruses as cause of human arthritic disease

GBF1, a guanine nucleotide exchange 10 factor for Arf, is crucial for coxsackievirus B3 RNA replication

The Identification and Characterization of Sindbis Virus RNA:Host Protein 13 Interactions

Accounting for the 15

Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets 16 to Compare Imputation Strategies

The SARS-CoV-2 RNA interactome

Mosquitoes as 20 Suitable Vectors for Alphaviruses. Viruses 10

Nuclear proteins hijacked by mammalian cytoplasmic plus strand 22 RNA viruses

Viral arthritis

25 (2019). hCLE/RTRAF-HSPC117-DDX1-FAM98B: A New Cap-Binding Complex That 26 Activates mRNA Translation

MobiDB: intrinsically 29 disordered proteins in 2021

HSPC117 is the 32 essential subunit of a human tRNA splicing ligase complex

Analysis of orthologous 34 groups reveals archease and DDX1 as tRNA splicing factors

Inhibition of host protein 36 synthesis by Sindbis virus: correlation with viral RNA replication and release of nuclear 37 proteins to the cytoplasm

The SARS-CoV-2 RNA-2 protein interactome in infected human cells

Chikungunya virus: epidemiology, replication, 4 disease mechanisms, and prospective intervention strategies

Identification of Interactions between Sindbis Virus Capsid 8 Protein and Cytoplasmic vRNA as Novel Virulence Determinants

The alphaviruses: gene expression, 11 replication, and evolution

Human mitochondrial mRNAs--like members of all families, similar but 14 different

Robust transcriptome-wide discovery of RNA-binding protein binding sites with 18 enhanced CLIP (eCLIP)

Translational resistance of late alphavirus mRNA to eIF2alpha 21 phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR

The 24 nucleolar protein GLTSCR2 is required for efficient viral replication

The cellular 26 RNA helicase DDX1 interacts with coronavirus nonstructural protein 14 and enhances 27 viral replication

Molecular Architecture of the SARS-CoV-2 Virus

4.4 A cryo-EM structure of an enveloped 33 alphavirus Venezuelan equine encephalitis virus

DDX1, DDX21, and DHX36 helicases form a complex with 36 the adaptor molecule TRIF to sense dsRNA in dendritic cells